Burcon Announces Results of Shareholder Meeting

Core Viewpoint - Burcon NutraScience Corporation has successfully obtained shareholder approval for key resolutions at its 2026 special meeting, including a private placement of convertible debentures and amendments to insider warrants [1][2]. Group 1: Shareholder Meeting Outcomes - All matters presented to shareholders were approved during the special meeting held on February 20, 2026 [1]. - Resolutions related to the Convertible Debenture Financing and amendments to the expiry date of outstanding warrants held by insiders received approval [2]. - A report detailing the voting results for each resolution has been filed on the SEDAR+ website [2]. Group 2: Financing and Future Expectations - The company anticipates closing the Convertible Debenture Financing around February 24, 2026 [3]. Group 3: Company Overview - Burcon is recognized as a global leader in high-performance plant-based proteins, catering to the food and beverage industry [4]. - The company boasts a robust patent portfolio covering proteins derived from various plant sources, including pea, canola, soy, hemp, and sunflower [4]. - Burcon is committed to sustainability and aims to provide innovative protein solutions that benefit both consumers and the environment [4].